LenioBio is a platform technology and solution provider pioneering protein expression with its ALiCE® platform, enabling rapid discovery, development, and scalable production of proteins beyond the limits of living cells. Founded in Germany in 2016, LenioBio is headquartered in Düsseldorf with R&D and manufacturing facilities in Aachen.
Our Mission is Clear:
To reduce development times and enable the production of medicines that were once considered unattainable. We believe ALiCE® holds the potential to reshape the future of medicine production and positively impact countless lives.
